Proteomika licenses HuCAL antibodies from AbD Serotec for use in Promonitor diagnostic kits May 16, 2011
Lantheus provides FDA advisory committees with safety data for ultrasound contrast agent Definity May 4, 2011
PET tracer BAY-86-4367 is safe in subjects with primary prostate cancer in phase I study April 21, 2011
New PET tracer BAY-94-9392 distinguishes tumors from inflammation in vivo; phase I trials ongoing April 12, 2011
RSS